The effects of oral nattokinase intake on blood fibrinolysis, coagulation and inflammatory profile during exercise

The effects of oral nattokinase intake on blood fibrinolysis, coagulation and inflammatory profile during exercise - The effects of oral nattokinase intake on blood fibrinolysis, coagulation and inflammatory profile during exercise

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027685

Enrollment

Registered

2017-06-18

Start date

2017-06-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult

Interventions

a single dose of 4,000 F.U. nattokinase intake a single dose of placebo intake

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Healthy males and females between 20 and 65 years old 2) Subjects who understand purpose and details of the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects who have a history of hematologic disease and symptoms of venous or arterial diseases. 2) Subjects being medicated

Design outcomes

Primary

Measure	Time frame
blood fibrinolysis (48 hours after intake)	—

Secondary

Measure	Time frame
1) blood coagulation 2) inflammatory	—

Countries

Japan

Contacts

Public ContactYuko Kurosawa

Tokyo Medical University Sports Medicine for Health Promotion

kurosawa@tokyo-med.ac.jp03-3351-6141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026